"The shifts in the financial markets, international forces and the 2008 election will have enormous impact on the future of new technology in healthcare. The Medical Innovation Summit provides unrivaled insights, exceptional networking and actionable takeaways for anyone who cares about medical innovation."
- Tim Ring, CR Bard
Past Speakers include:
CEOS of GE, Johnson & Johnson, Eli Lilly, Abbott, AstraZeneca, Amgen, Boston Scientific, 3M, Medtronic and Edwards Lifesciences; partners from top venture firms, heads of Government agencies and top clinicians.
IN MEMORIAM
Andrew C. Novick, MD
1948 - 2008


Cleveland, Ohio  |  InterContinental Hotel & Bank of America Conference Center

2009 Medical Innovation Summit

Favorable Prognosis:
Cancer Cures Through Innovation

October 5 - 7, 2009
Cleveland, Ohio

REGISTER NOW

Join more than 900 senior executives, investors, entrepreneurs and clinicians who will gather at Cleveland Clinic this fall to discover the future of medicine.

Summit highlights include:

Candid exchanges with investors and executives who are shaping the future of medical innovation.

World leaders who are creating entirely new health care opportunities.

Detailed insights into the newest innovations in the fast growing oncology markets.

First hand analysis on new directions for supporting innovation.

Top 10 Medical Innovations for 2010.

2008 Medical Innovation Summit

Witness the innovation revolution.
Invest in the future of medicine.
Envision the limitless possibilities.

Join Robert Rubin, Citigroup, Jim Tobin, Boston Scientific, Tim Ring, CR Bard, Karen Licitra, Johnson & Johnson, Senator Ron Wyden (D-OR), Tommy Thompson, former Secretary of the Department of Health and Human Services and other leading experts in the field at the 6th Annual Medical Innovation Summit. Take advantage of our exciting lineup of speakers, panel discussions and clinical presentations to learn about the latest trends in medical innovation and what they mean to you.

The Summit provides an unrivaled perspective on the newest medical technologies and the financial drivers behind those innovations. It is dedicated to providing singular insights, networking opportunities and actionable take aways for all participants.

Summit highlights include:
  • Candid exchanges with leaders who are shaping the future of medical technology
  • First hand analysis on new directions for supporting innovation post the historic 2008 election
  • World leaders who are shaping health care opportunities in important international markets
  • Detailed insights into the newest innovations in the fast growing urology and gynecology markets including live, interactive surgery
  • Top 10 Medical Innovations for 2009

Join the more than 900 senior executives, investors, entrepreneurs and clinicians, who will gather at the Cleveland Clinic this fall to discover the future of medicine.

View the agenda and reserve your seat today.

Robert Rubin, Citigroup
John Dineen, GE Healthcare
Jim Tobin, Boston Scientific
Karen Licitra, Johnson & Johnson
Alfred Spector, Google
Richard Roth, CNN
Peter Neupert, Microsoft
Mike Connolly, Mirabilis
Ross Longhini, AMS
John Kelly, PhD, IBM
Frederic Moll, MD, Hansen Medical
John Rewcastle, PhD, EDAP TMS
Clement Vidal, EndoControl
Kerry Pope, Novare Surgical Systems
Woojin Lee, MD, CambridgeEndo
Richard Emmitt, Vertical Group
Joan Meyer, PhD, P&G Pharmaceuticals
David Robinson, MD, Ethicon Women's Health
and Urology
Wulf Utian, MD, PhD, North American Menopause Society
Michael Greeley, Flybridge Capital Partners
John Kurhanewicz, PhD, UCSF, Mission Bay
Kobi Vortman, MD, InSightec
Glen Bolger, Public Opinion Strategies
Andre Guay, MD, Center for Sexual Function
Michael Tarnoff, MD, Surgical Devices Global Business Unit
Stephen Levin, FDC/Windhover
Michael C. Wiemann, MD, St. John Health
Tommy Thompson, Former Secretary, Department of Health and Human Services
Tim Ring, CR Bard
Maria Bartiromo, CNBC
Steve Oesterle, MD, Medtronic
Larry Keeley, Doblin
Martin Emerson, Galil Medical
Lisa Martinez, RN, Women's Sexual Health Foundation
Dana Mead, Kleiner Perkins
Harry Rein, Foundation Medical Partners
Kevin Quilty, Endocare
Chris Jennings, Jennings Policy Strategies
Ronald Riner, MD, The Riner Group
Frank Bonadio, Advanced Surgical Concepts
Eric Halvorson, Olympus America
Anthony Atala, MD, Tengion
Gregory Piskun, MD, Pnavel Systems
Craig Wynett, P&G
Bruce German, Nestle Research Center
Charlie Cook, The Cook Political Report
Thalia Assuras, CBS
Jan Garfinkle, Arboretum Ventures
Peter Klemm, PhD, Predictive Biosciences
Manar Al-Moneef, MD, SAGIA Health and Life Science
Ron Wyden, U.S. Senator-Oregon
Tom Kelly, PhD, Enterprise Ireland
Anthony N. Kalloo, MD, Johns Hopkins Hospital
Nicolaus Henke, McKinsey
Monday,
November 10, 2008
12 - 7 P.M. Registration
12 P.M. Exhibits Open, Light Refreshments
6:30 - 10 P.M. Opening Reception, Dinner & Entertainment

Tuesday,
November 11, 2008
6:30 A.M. - 2 P.M. Registration
6:30 - 7:30 A.M. Continental Breakfast
7 A.M. - 7 P.M. Exhibits Open
6 - 7 P.M. Welcome Reception
7 P.M. Dinner: Founders Ballroom
View Detailed Agenda - NOW AVAILABLE
Wednesday,
November 12, 2008
6:30 - 9 A.M. Registration
6:30 - 7:30 A.M. Continental Breakfast
7 A.M. - 2 P.M. Exhibits Open
2:30 - 2:45 P.M. Wrap Up
- Senior executives at medical device firms
- Clinical, medical affairs, regulatory and business development executives and their teams
- Venture capitalists and angel investor groups
- Investment bankers
- Buy-side and sell-side researchers
- Consulting, legal and other service providers